Skip to main content

Animations

MJFF Publications

5301 - 5310 of 9182 Results
Title
Year
  • Year
  • 2018
  • 2011
  • 2017
  • 2011
  • 2013
  • 2009
  • 2014
  • 2014
  • 2016
  • 2009
  • Summary Details
    OPEN
    Title: Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0052-6
    Citation Count: 93
  • Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    2011
    Summary Details
    RESTRICTED
    Title: Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    Journal Name: Narrative Inquiry in Bioethics
    Publisher: Project MUSE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1353/nib.2011.0046
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Integrated molecular landscape of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0015-3
    Citation Count: 126
  • Summary Details
    OPEN
    Title: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
    Journal Name: Nature Chemical Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchembio.538
    Citation Count: 431
  • Summary Details
    OPEN
    Title: Atypical presentation of late‐onset Tay‐sachs disease
    Journal Name: Muscle & Nerve
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mus.24146
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal models
    Journal Name: Nature Chemical Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchembio.193
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0096675
    Citation Count: 222
  • Summary Details
    OPEN
    Title: DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0106601
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/ncomms10332
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
    Journal Name: Current Alzheimer Research
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2174/156720509788929318
    Citation Count: 34
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.